These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20545323)

  • 1. Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2.
    Chandrashekaran IR; Adda CG; MacRaild CA; Anders RF; Norton RS
    Biochemistry; 2010 Jul; 49(28):5899-908. PubMed ID: 20545323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid-like fibrils.
    Yang X; Adda CG; Keizer DW; Murphy VJ; Rizkalla MM; Perugini MA; Jackson DC; Anders RF; Norton RS
    J Pept Sci; 2007 Dec; 13(12):839-48. PubMed ID: 17883245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGCG disaggregates amyloid-like fibrils formed by Plasmodium falciparum merozoite surface protein 2.
    Chandrashekaran IR; Adda CG; Macraild CA; Anders RF; Norton RS
    Arch Biochem Biophys; 2011 Sep; 513(2):153-7. PubMed ID: 21784057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the helical structure of the N-terminal region of Plasmodium falciparum merozoite surface protein 2 in fibril formation and membrane interaction.
    Zhang X; Adda CG; Low A; Zhang J; Zhang W; Sun H; Tu X; Anders RF; Norton RS
    Biochemistry; 2012 Feb; 51(7):1380-7. PubMed ID: 22304430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Merozoite surface protein 2 of Plasmodium falciparum: expression, structure, dynamics, and fibril formation of the conserved N-terminal domain.
    Low A; Chandrashekaran IR; Adda CG; Yao S; Sabo JK; Zhang X; Soetopo A; Anders RF; Norton RS
    Biopolymers; 2007 Sep; 87(1):12-22. PubMed ID: 17516503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils.
    Adda CG; Murphy VJ; Sunde M; Waddington LJ; Schloegel J; Talbo GH; Vingas K; Kienzle V; Masciantonio R; Howlett GJ; Hodder AN; Foley M; Anders RF
    Mol Biochem Parasitol; 2009 Aug; 166(2):159-71. PubMed ID: 19450733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key residues involved in fibril formation by the conserved N-terminal region of Plasmodium falciparum merozoite surface protein 2 (MSP2).
    Yang X; Adda CG; MacRaild CA; Low A; Zhang X; Zeng W; Jackson DC; Anders RF; Norton RS
    Biochimie; 2010 Oct; 92(10):1287-95. PubMed ID: 20542076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
    J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-specific humoral response to a polymorphic malaria vaccine.
    Flück C; Smith T; Beck HP; Irion A; Betuela I; Alpers MP; Anders R; Saul A; Genton B; Felger I
    Infect Immun; 2004 Nov; 72(11):6300-5. PubMed ID: 15501757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet.
    Ohnishi S; Koide A; Koide S
    J Mol Biol; 2000 Aug; 301(2):477-89. PubMed ID: 10926522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium falciparum: distribution of msp2 genotypes among symptomatic and asymptomatic individuals from the Wosera region of Papua New Guinea.
    Cortés A; Mellombo M; Benet A; Lorry K; Rare L; Reeder JC
    Exp Parasitol; 2004; 106(1-2):22-9. PubMed ID: 15013785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity.
    Flück C; Schöpflin S; Smith T; Genton B; Alpers MP; Beck HP; Felger I
    Infect Genet Evol; 2007 Jan; 7(1):44-51. PubMed ID: 16647307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution conformation, backbone dynamics and lipid interactions of the intrinsically unstructured malaria surface protein MSP2.
    Zhang X; Perugini MA; Yao S; Adda CG; Murphy VJ; Low A; Anders RF; Norton RS
    J Mol Biol; 2008 May; 379(1):105-21. PubMed ID: 18440022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The merozoite surface protein 2 (MSP2) gene of Plasmodium falciparum from a Thai isolate.
    Jongwutiwes S; Putaporntip C
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S33-9. PubMed ID: 9071065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.
    Genton B; Betuela I; Felger I; Al-Yaman F; Anders RF; Saul A; Rare L; Baisor M; Lorry K; Brown GV; Pye D; Irving DO; Smith TA; Beck HP; Alpers MP
    J Infect Dis; 2002 Mar; 185(6):820-7. PubMed ID: 11920300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.
    Adda CG; MacRaild CA; Reiling L; Wycherley K; Boyle MJ; Kienzle V; Masendycz P; Foley M; Beeson JG; Norton RS; Anders RF
    Infect Immun; 2012 Dec; 80(12):4177-85. PubMed ID: 22966050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
    Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
    Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of merozoite surface protein 2 with lipid membranes.
    Lu C; Zheng X; Zhang W; Zhao H; MacRaild CA; Norton RS; Zhuang Y; Wang J; Zhang X
    FEBS Lett; 2019 Feb; 593(3):288-295. PubMed ID: 30588612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.